Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Payables: 2010-2024

Historic Payables for Vanda Pharmaceuticals (VNDA) over the last 15 years, with Dec 2024 value amounting to $39.1 million.

  • Vanda Pharmaceuticals' Payables rose 21.16% to $47.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.1 million, marking a year-over-year increase of 21.90%. This contributed to the annual value of $39.1 million for FY2024, which is 1.63% up from last year.
  • Per Vanda Pharmaceuticals' latest filing, its Payables stood at $39.1 million for FY2024, which was up 1.63% from $38.5 million recorded in FY2023.
  • In the past 5 years, Vanda Pharmaceuticals' Payables ranged from a high of $45.6 million in FY2022 and a low of $31.5 million during FY2020.
  • In the last 3 years, Vanda Pharmaceuticals' Payables had a median value of $39.1 million in 2024 and averaged $41.0 million.
  • Per our database at Business Quant, Vanda Pharmaceuticals' Payables spiked by 32.27% in 2022 and then dropped by 15.57% in 2023.
  • Over the past 5 years, Vanda Pharmaceuticals' Payables (Yearly) stood at $31.5 million in 2020, then increased by 9.30% to $34.4 million in 2021, then surged by 32.27% to $45.6 million in 2022, then dropped by 15.57% to $38.5 million in 2023, then rose by 1.63% to $39.1 million in 2024.